130 related articles for article (PubMed ID: 1303676)
1. Anti-diabetogenic effect of fusidic acid in diabetes prone BB rats.
Buschard K; Pedersen C; Hansen SV; Hageman I; Aaen K; Bendtzen K
Autoimmunity; 1992; 14(2):101-4. PubMed ID: 1303676
[TBL] [Abstract][Full Text] [Related]
2. Effect of fusidic acid on interleukin-1 (IL-1)- and IL-6-induced pancreatic beta-cell functions in rats.
Bendtzen K; Diamant M; Horn T; Pedersen C; Buschard K
J Endocrinol; 1992 Mar; 132(3):345-52. PubMed ID: 1564418
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetogenic effect of fusidic acid in diabetes prone BB rats: a sex-dependent organ accumulation of the drug is seen.
Hageman I; Buschard K
Pharmacol Toxicol; 2002 Sep; 91(3):123-8. PubMed ID: 12427112
[TBL] [Abstract][Full Text] [Related]
4. Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma.
Nicoletti F; Di Marco R; Morrone S; Zaccone P; Lembo D; Grasso S; Santoni A; Meroni PL; Bendtzen K
Immunology; 1994 Feb; 81(2):317-21. PubMed ID: 8157281
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats.
Zipris D; Greiner DL; Malkani S; Whalen B; Mordes JP; Rossini AA
J Immunol; 1996 Feb; 156(3):1315-21. PubMed ID: 8558012
[TBL] [Abstract][Full Text] [Related]
6. Morphological effects of sodium fusidate (fusidin) on pancreatic islet cells: an electron microscopic study.
Horn T; Bendtzen K; Hageman I; Buschard K
Pharmacol Toxicol; 1994; 75(3-4):228-30. PubMed ID: 7800668
[TBL] [Abstract][Full Text] [Related]
7. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610.
Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM
J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285
[TBL] [Abstract][Full Text] [Related]
9. Insulitis and mechanisms of disease resistance: studies in an animal model of insulin dependent diabetes mellitus.
Bone AJ; Hitchcock PR; Gwilliam DJ; Cunningham JM; Barley J
J Mol Med (Berl); 1999 Jan; 77(1):57-61. PubMed ID: 9930928
[TBL] [Abstract][Full Text] [Related]
10. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock.
Nicoletti F; Zaccone P; Di Marco R; Magro G; Grasso S; Morrone S; Santoni A; Tempera G; Meroni PL; Bendtzen K
Immunology; 1995 Aug; 85(4):645-50. PubMed ID: 7558161
[TBL] [Abstract][Full Text] [Related]
11. Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730.
Jobe LW; Ubungen R; Goodner CJ; Baskin DG; Braquet P; Lernmark A
Autoimmunity; 1993; 16(4):259-66. PubMed ID: 8025205
[TBL] [Abstract][Full Text] [Related]
12. Effects of a protective hydrolyzed casein diet upon the metabolic and secretory responses of pancreatic islets to IL-1beta, cytokine production by mesenteric lymph node cells, mitogenic and biosynthetic activities in Peyer's patch cells, and mitogenic activity in pancreatic lymph node cells from control and diabetes-prone BB rats.
Olivares E; Ladrière L; Laghmich A; Sener A; Malaisse WJ; Scott FW
Mol Genet Metab; 1999 Nov; 68(3):379-90. PubMed ID: 10562466
[TBL] [Abstract][Full Text] [Related]
13. Glimepiride-induced prevention of diabetes and autoimmune events in the BB rat: revised.
Cheta DM; Lim J; Chan EK; Kunakorn T; Charles MA
Life Sci; 1995; 57(24):2281-90. PubMed ID: 7475982
[TBL] [Abstract][Full Text] [Related]
14. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant.
Sadelain MW; Qin HY; Sumoski W; Parfrey N; Singh B; Rabinovitch A
J Autoimmun; 1990 Dec; 3(6):671-80. PubMed ID: 2088390
[TBL] [Abstract][Full Text] [Related]
15. Genetically determined differences in newborn rat islet sensitivity to interleukin-1 in vitro: no association with the diabetes prone phenotype in the BB-rat.
Andersen HU; Mandrup-Poulsen T; Egeberg J; Helqvist S; Nerup J
Acta Endocrinol (Copenh); 1989 Jan; 120(1):92-8. PubMed ID: 2643251
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of type 1 diabetes and an insulin-producing cell line.
Sigfrid LA; Cunningham JM; Beeharry N; Håkan Borg LA; Rosales Hernandez AL; Carlsson C; Bone AJ; Green IC
J Mol Med (Berl); 2004 May; 82(5):325-35. PubMed ID: 15007513
[TBL] [Abstract][Full Text] [Related]
17. Long-term prophylactic insulin treatment can prevent spontaneous diabetes and thyroiditis development in the diabetes-prone bio-breeding rat, while short-term treatment is ineffective.
Visser J; Klatter F; Vis L; Groen H; Strubbe J; Rozing J
Eur J Endocrinol; 2003 Sep; 149(3):223-9. PubMed ID: 12943525
[TBL] [Abstract][Full Text] [Related]
18. Prevention of diabetes in BB/Wor rats by intrathymic islet injection.
Koevary SB; Blomberg M
J Clin Invest; 1992 Feb; 89(2):512-6. PubMed ID: 1737841
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 beta (IL-1) does not reduce the diabetes incidence in diabetes-prone BB rats.
Reimers JI; Mørch L; Markholst H; Wogensen LD; Andersen HU; Mandrup-Poulsen T; Nerup J
Autoimmunity; 1994; 17(2):105-18. PubMed ID: 8061161
[TBL] [Abstract][Full Text] [Related]
20. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats.
Satoh J; Shintani S; Oya K; Tanaka S; Nobunaga T; Toyota T; Goto Y
Diabetes; 1988 Sep; 37(9):1188-94. PubMed ID: 3044884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
